People: SciGen Ltd (SIE.AX)

SIE.AX on Australia Stock Exchange

0.02AUD
4 Aug 2014
Price Change (% chg)

$-0.00 (-10.00%)
Prev Close
$0.02
Open
$0.01
Day's High
$0.02
Day's Low
$0.01
Volume
30,000
Avg. Vol
1,338
52-wk High
$0.06
52-wk Low
$0.01

Search Stocks

Summary

Name Age Since Current Position

Slawomir Ziegert

47 2011 Executive Chairman of the Board, Chief Executive Officer

Adam Polonek

36 2012 Chief Financial Officer, Non-Executive Director

Saw Imm Low

61 2009 Senior Vice President, Company Secretary, Executive Director

Tova Katz

2011 Acting General Manager, Israel

Yvonne Lim

2010 Group Financial Controller

Jean-Claude Balducci

Country Manager, Australia and New Zealand

Liza Domingo

Country Manager, Philippines

Li Minyi

2011 Accounts Executive

Hedy Ong

2011 Finance and Logistics Manager

Marcus Poh

Regional Marketing Manager

Chander Sharma

Business Development Executive

Edward Thomas

2011 Business Development Executive

Sharon Walters

Business Development Executive

Leng Wong Lai

2002 Company Secretary

Marcin Dukaczewski

2008 Non-Executive Director

Mateusz Kosecki

38 2009 Non-Executive Director

Adam Wilczega

58 2005 Non-Executive Director

Kenneth Gross

83 Independent Non-Executive Director

Biographies

Name Description

Slawomir Ziegert

Mr. Slawomir Ziegert serves as Executive Chairman of the Board and Chief Executive Officer of SciGen Ltd since April 14, 2011. He was appointed as Chief Executive Officer and Director on December 2, 2009. He is a medical doctor, graduate of the Medical University in Gdansk (Gdanski Uniwersytet Medyczny). He has been connected with the pharmaceutical industry for over 16 years, working in Poland and abroad for such concerns as Eli Lilly, Egis Group (a part of Servier Group) and Ipsen. He has business experience covering different sectors of the pharmaceutical industry, including biotechnology, in particular business development within the scope of endocrinology and treatment of diabetes. From 1993 to 2004, he worked in the Polish branch of Eli Lilly. In 1998 to 2000, he was also Eli Lilly’s Country Manager in Slovakia. In 2004 to 2005, he was CEO of Egis Pharmaceuticals (a part of Servier Group). In 2006 to 2009, he was CEO of Ipsen Poland. Since November 9, 2009, he has been holding the position of the President of the Managing Board of Bioton S.A. and is CEO of the Company.

Adam Polonek

Mr. Adam Tomasz Polonek serves as Chief Financial Officer and Non-Executive Director of SciGen Ltd since January 12, 2012. He was appointed as Non-Executive Director on June 26, 2008. He is a graduate of the Economic Faculty at Academy of Economics in Poland. Mr. Polonek joined Bioton S.A. in 2006 as Deputy Finance Director and since April 2009 as the Finance Director. Mr. Polonek holds finance-related positions in other subsidiaries of SciGen and the Bioton Group. His experience includes career in CEE Europe, CAIB Financial Advisers, part of Group Unicredit in Europe.

Saw Imm Low

Ms. Saw Imm (Jenny) Low serves as Senior Vice President, Company Secretary and Executive Director of SciGen Ltd. She was appointed as Senior Vice President on September 26, 2006, and served as Chief Financial Officer until September 26, 2006. She is a Chartered Accountant and has held accountancy positions in various companies in Malaysia and Singapore. She has over 30 years of accounting experience. Before joining SciGen in September 1991, Ms. Low was with Abacus Distribution Systems Pte Ltd.

Tova Katz

Yvonne Lim

Jean-Claude Balducci

Liza Domingo

Li Minyi

Hedy Ong

Marcus Poh

Chander Sharma

Edward Thomas

Sharon Walters

Leng Wong Lai

Marcin Dukaczewski

Mr. Marcin Dukaczewski serves as Non-Executive Director of SciGen Ltd since December 26, 2008. Mr. Marcin Dukaczewski was trained in International Political and Economical Relations at the Warsaw University (Uniwersytet Warszawski). Mr. Dukaczewski holds the position of Vice President of the Management Board of Prokom Investments – a Polish private-equity fund being the strategic investor in Bioton S.A. Mr. Dukaczewski is also a member of the Supervisory Board of public listed companies listed on the Warsaw Stock Exchange: Bioton (biotechnology), Petrolinvest (oil & gas exploration) and Polnord (real estate development). Mr. Dukaczewski is also a member of the Supervisory Board of Biolek (veterinary products), Silurian (shale gas exploration) and a member of the Board of Directors of Biolek, Inc in Canada.

Mateusz Kosecki

Mr. Mateusz Patryk Kosecki serves as Non-Executive Director of SciGen Ltd since December 1, 2009. Mr. Mateusz Kosecki is a graduate of the Executive MBA Program of European University, Montreux, Switzerland. Mr. Kosecki is the Foreign Markets Director of Bioton S.A. and is responsible for the operations of the company on overseas market. Mr. Kosecki is also the Vice President of Biolek Sp z.o.o., a member of Bioton Group. Mr. Kosecki has experience in international business. From 1995 to 1996 he worked as the Marketing Manager in Lenex Company in Sofia, Bulgaria. From 1997 to 2001 he was Head of Foreign Corporate Governance and Operations of Ciech S.A. He has been connected with pharmaceutical industry for 10 years. From 2002 to 2006, as the Country Manager for Russia of the Polish pharmaceutical company Ciech Polfa, and from 2006 to 2009 as Regional Director for Eastern Europe in Bioton S.A.

Adam Wilczega

Mr. Adam Wilczega serves as Non-Executive Director of SciGen Ltd since April 11, 2005. Mr. Adam Wilczega is a graduate of Warsaw School of Economics (Szkola Glowna Handlowa w Warszawie), where he obtained the title of MSc in Economics. In 1991, he completed managers training in Japan. His professional career started in 1979 at PTHZ Varimex in Warsaw where he worked as a section manager until 1984. In 1984 to 1989, he was employed as a director of Technical and Trade Information Centre in Cairo, Egypt. Then, in the period 1989 to 1991, he held the position of the Director of PTHZ Varimex in Warsaw. In 1991 to 1996, he was the president of the managing board of Future Trading Co. Sp. z o.o. (limited liability company) in Warsaw. He has been working in Bioton S.A. since 1996, when he became director for foreign co-operation and a Member of the Managing Board. Since 1998, he has been the president of the managing board of Bioton Trade Sp. z o.o. From 1997 until January 15, 2009, he was holding the post of the President of the Managing Board of Bioton S.A. Since January 15, 2009, he has been Vice President of the Managing Board and since March 2009, he has been holding the post of Director for Foreign Markets of the Company.

Kenneth Gross

Mr. Kenneth Gross is Independent Non-Executive Director of SciGen Ltd. Mr. Kenneth Gross co-founded Goldmark Plastic Compounds in 1957. The Company has since become a distributor of plastic raw materials within the United States. In addition, Mr. Gross holds a number of directorships in various companies involved in chemical, metals, engineering resins and lubricating oils.

Basic Compensation

Search Stocks